Skip to main content
. Author manuscript; available in PMC: 2009 Sep 11.
Published in final edited form as: Nat Genet. 2008 May;40(5):546–552. doi: 10.1038/ng.134

Table 1.

Differentially expressed genes in human cardiac hypertrophy and associated with indexed left ventricular mass

Probe identifier Gene symbol Gene name Relative changea FDRb (%) Correlation with LVMc P valued
218730_s_at OGN Osteoglycin 2.2 2.7 0.62 1.2 × 10−3
202766_s_at FBN1 Fibrillin 1 2.0 2.7 0.55 4.5 × 10−3
209621_s_at PDLIM3 PDZ and LIM domain 3 1.6 5.0 0.52 6.5 × 10−3
219087_at ASPN Asporin 1.9 5.0 0.52 7.5 × 10−3
213646_x_at TUBA1B Tubulin, alpha 1b 1.5 2.7 0.52 5.7 × 10−3
213765_at MFAP5 Microfibrillar associated protein 5 1.8 5.0 0.51 6.8 × 10−3
203570_at LOXL1 Lysyl oxidase-like 1 1.5 5.0 0.51 8.1 × 10−3
208782_at FSTL1 Follistatin-like 1 1.5 2.7 0.51 1.1 × 10−2
213867_x_at ACTB Actin, beta 1.5 2.7 0.49 1.1 × 10−2
212614_at ARID5B AT rich interactive domain 5B 1.6 2.7 0.49 9.9 × 10−3
216442_x_at FN1 Fibronectin 1 1.9 5.0 0.49 1.1 × 10−2
211750_x_at TUBA1C Tubulin, alpha 1c 1.6 2.7 0.48 1.3 × 10−2
212582_at OSBPL8 Oxysterol binding protein-like 8 1.6 2.7 0.48 1.1 × 10−2
221729_at COL5A2 Collagen, type V, alpha 2 1.9 5.0 0.48 1.3 × 10−2
201843_s_at EFEMP1 EGF- fibulin-like extracellular matrix protein 1 1.8 5.0 0.48 1.2 × 10−2
202007_at NID1 Nidogen 1 1.6 2.7 0.47 1.6 × 10−2
203548_s_at LPL Lipoprotein lipase 1.8 2.7 0.47 1.7 × 10−2
205547_s_at TAGLN Transgelin 2.1 2.7 0.46 1.7 × 10−2
202552_s_at CRIM1 Cysteine rich transmembrane BMP regulator 1 1.6 3.9 0.46 1.9 × 10−2
201012_at ANXA1 Annexin A1 1.6 2.7 0.46 1.7 × 10−2
209460_at ABAT 4-aminobutyrate aminotransferase 1.6 2.7 0.45 2.0 × 10−2
201302_at ANXA4 Annexin A4 1.5 3.9 0.44 2.1 × 10−2
219260_s_at C17orf81 Chromosome 17 open reading frame 81 1.5 2.7 0.44 2.4 × 10−2
209130_at SNAP23 Synaptosomal-associated protein,
23kda
1.5 5.0 0.44 2.6 × 10−2
209392_at ENPP2 Ectonucleotide pyrophosphatase/
phosphodiesterase 2
1.6 2.7 0.43 2.7 × 10−2
200974_at ACTA2 Actin, alpha 2, smooth muscle, aorta 1.6 2.7 0.43 2.8 × 10−2
210942_s_at ST3GAL6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 1.5 5.0 0.42 3.3 × 10−2
212063_at CD44 CD44 molecule 1.9 3.9 0.42 3.0 × 10−2
212515_s_at DDX3X DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked 1.5 5.0 0.41 3.6 × 10−2
211509_s_at RTN4 Reticulon 4 1.6 3.9 0.41 3.7 × 10−2
209387_s_at TM4SF1 Transmembrane 4 L six family member 1 1.8 2.7 0.40 4.0 × 10−2
219922_s_at LTBP3 Latent transforming growth factor beta binding protein 3 1.5 5.0 0.40 4.3 × 10−2
202119_s_at CPNE3 Copine III 1.5 3.9 0.40 4.8 × 10−2
210095_s_at IGFBP3 Insulin-like growth factor binding protein 3 1.7 2.7 0.39 5.0 × 10−2
a

Relative change in expression between subjects with low (≤93 g/m2) and high (≥142 g/m2) LVM in the study population.

b

False discovery rate for differential expression, estimated by SAM analysis.

c

Data are ranked according to decreasing values of the Pearson correlation with LVM (determined noninvasively by echocardiography).

d

Empirical P values for the correlations were calculated by 10,000 permutations.